|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Inhibikase Therapeutics, Inc. (IKT) |
|
|
$0.61 0.00 (0.00%) as of 4:30 Thu 6/29
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
74,340,000 |
| Market
Cap: |
45.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.61 - $0.61 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inhibikase Therapeutics is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Disease and related disorders that arise inside and outside of the brain. Co. has commenced clinical development of IkT-148009, a small molecule Abelson Tyrosine Kinase inhibitor. Co. has also advanced clinical batch manufacturing and pill formulation for its platform prodrug technology involving IkT-001Pro. Co.'s platform drug discovery and delivery technologies have identified additional opportunities, including a treatment for bacterial or viral infections in the brain using a single agent at fixed dose, and an oncology opportunity in stable-phase Chronic Myelogenous Leukemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,068,965 |
2,068,965 |
2,068,965 |
4,038,965 |
| Total Buy Value |
$2,999,999 |
$2,999,999 |
$2,999,999 |
$5,698,899 |
| Total People Bought |
1 |
1 |
1 |
4 |
| Total Buy Transactions |
1 |
1 |
1 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-08-28 |
2025-05-27 |
2024-11-26 |
2023-11-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sands Frank M. |
10% Owner |
– – • |
2025-11-21 |
4 |
B |
$1.45 |
$2,999,999 |
D/D |
2,068,965 |
13,018,965 |
2.45 |
- |
|
| Sands Frank M. |
10% Owner |
– – • |
2025-06-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
10,950,000 |
|
- |
|
| Mcintyre David |
Chief Financial Officer |
• – – |
2025-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,285 |
|
- |
|
| Cabell Christopher |
President & Head of R&D |
• – – |
2025-02-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,014,846 |
|
- |
|
| Vincent Aurentz |
|
– • – |
2025-02-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
765,895 |
|
- |
|
| Munshi Amit |
|
– • – |
2025-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
57,265 |
57,265 |
|
- |
|
| Kush Arvind |
|
– • – |
2024-10-21 |
4 |
B |
$1.37 |
$198,650 |
D/D |
145,000 |
145,000 |
0.01 |
- |
|
| Bellini Roberto |
|
– • – |
2024-10-21 |
4 |
B |
$1.37 |
$2,000,200 |
I/I |
1,460,000 |
1,460,000 |
0.01 |
- |
|
| Munshi Amit |
|
– • – |
2024-10-21 |
4 |
B |
$1.37 |
$500,050 |
I/I |
365,000 |
365,000 |
0.01 |
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2022-08-16 |
4 |
B |
$0.80 |
$4,000 |
D/D |
5,000 |
5,335,433 |
3.15 |
-39% |
|
| Werner Milton H. |
President and CEO |
• • • |
2022-05-27 |
4 |
B |
$0.98 |
$4,880 |
D/D |
5,000 |
5,330,433 |
3.15 |
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2022-05-20 |
4 |
B |
$0.60 |
$6,000 |
D/D |
10,000 |
5,325,433 |
3.15 |
- |
|
| Frattaroli Joseph |
Chief Financial Officer |
• – – |
2022-05-19 |
4 |
B |
$0.64 |
$2,543 |
D/D |
3,948 |
48,091 |
2.66 |
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2022-01-03 |
4 |
OE |
$2.02 |
$44,143 |
D/D |
21,853 |
5,315,433 |
|
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2021-11-17 |
4 |
B |
$1.93 |
$46,558 |
I/I |
23,589 |
23,589 |
2.64 |
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2021-08-17 |
4 |
OE |
$2.02 |
$44,143 |
D/D |
21,853 |
5,293,580 |
|
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2021-05-14 |
4 |
D |
$4.59 |
$77,654 |
D/D |
(16,918) |
5,271,727 |
|
- |
|
| Werner Milton H. |
President and CEO |
• • • |
2021-05-14 |
4 |
OE |
$0.38 |
$16,609 |
D/D |
43,707 |
5,288,645 |
|
- |
|
| Frattaroli Joseph |
Chief Financial Officer |
• – – |
2020-12-28 |
4 |
OE |
$10.00 |
$441,430 |
I/I |
44,143 |
44,143 |
|
- |
|
| Werner Milton H. |
President and CEOOfficer |
• • • |
2020-12-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,244,938 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
